Reach our editorial and research team — we respond to serious inquiries within one business day
Request institutional-grade cannabis market intelligence, data access, or custom reports.
Disclaimer: Cannabis Investor News is for informational purposes only—not investment advice. We are not registered with the SEC, FINRA, or any regulatory body. Data may be delayed or inaccurate. Cannabis securities carry significant risk; you could lose your entire investment. Always consult a licensed financial advisor and verify all information independently before making any investment decision.
Contact Cannabis Investor News for institutional research inquiries, data licensing, media requests, and partnership opportunities. CIN serves professional cannabis investors, portfolio managers, institutional research teams, family offices, and cannabis industry executives seeking institutional-grade market intelligence.
Our contact form routes inquiries to the appropriate team based on subject area: investment research access, custom report requests, data licensing and API integration, advertising and sponsorship, media and press inquiries, and general questions about the CIN platform and methodology. Cannabis Investor News is a product of CanIDeal, a cannabis industry technology and intelligence company headquartered in Marina del Rey, California. CanIDeal develops data platforms and analytical tools for the cannabis investment community, with a focus on bridging the information gap between cannabis operators and institutional capital.
For institutional investors seeking customized cannabis sector research, CIN offers complimentary research reports covering market sizing, competitive landscape analysis, regulatory impact assessments, and sector-specific investment theses. Report requests can be submitted through the contact form with details about your investment focus, portfolio size, and specific research needs. CIN is not a registered investment adviser and published content is for informational purposes only.